Purpose of the Study

Helios Clinical Research is conducting a clinical research study in healthy infants.
The purpose of this study is to evaluate the safety, tolerability, and immune response of an investigational pneumococcal vaccine. Helios Clinical Research is seeking parents/legal guardians of eligible infants to learn whether their child may qualify to participate.

Study Requirements

Your child may qualify if:


They will be 42 to 98 days old at the time of participation
They are generally healthy

Potential Benefits of Participation

Maginfying

Access to new treatments that are
not yet available to the general public.

Hand Heart

Personalized medical attention from
leading healthcare professionals.

Helios

Compensation provided to qualified participants

Study Locations

These studies are currently enrolling at the following sites:

Helios Clinical Research - Little Rock, AR

About Helios Clinical

Helios Clinical is dedicated to advancing medical research through innovative clinical trials.
Our mission is to discover new ways to improve patient health and outcomes.
We collaborate with leading healthcare professionals and scientists
to ensure the highest standards of research and care for our participants.